COMMUNIQUÉS West-GlobeNewswire

ICC Labs Announces Shareholder Approval of Arrangement With Aurora Cannabis
06/11/2018
VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC ) (TSX-V: ICC) is pleased to announce that, at the special meeting of shareholders of ICC ( ICC Shareholders ) held today [...]
CLS Holdings USA Closes $5.9 Million Private Placement
06/11/2018
Provides Additional Growth Capital Led by Navy Capital, a Leading Cannabis Focused Institution LAS VEGAS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company [...]
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $40 Million of Common Stock
06/11/2018
DALLAS and FORT WORTH, Texas, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a fully-integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative [...]
Obalon Announces Upcoming Conference Presentations
06/11/2018
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
How to Invest in Cannabis Beverages -- CFN Media
06/11/2018
SEATTLE, Nov. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Physeon Receives Institutional Review Board Approval to Commence US “VIVA” Trial for Veinplicity at Second Site
06/11/2018
Recent Clinical Study Indicated Device had a Dilatory Effect 38% Greater than other Common Approaches for Veins Targeted for IV Access. Other studies indicate a First IV Stick Success Much Greater Than the Standard of [...]
NewLink Genetics Announces Publication of Abstracts for Presentation at the Society for Immunotherapy for Cancer (SITC) Conference
06/11/2018
AMES, Iowa, Nov. 06, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that the following abstracts have been published and are now available on the Society for Immunotherapy of Cancer [...]
Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial
06/11/2018
Receives commitment for $20 million in proceeds from equity private placement Restructures and extends maturity on $13.5 million of outstanding senior secured notes CRANBURY, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- [...]
Rolling Strong Announces Partnership with eTrueNorth
06/11/2018
Health and wellness platform provider enhances its support of truck drivers with healthcare services at local pharmacies RIVERSIDE, Mo., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Rolling Strong, the provider of driver wellness [...]
Rafael Pharmaceuticals Appoints Vice President, Manufacturing and CMC Regulatory Affairs and Vice President of Regulatory Affairs to Strengthen Development of CPI-613
06/11/2018
Newark, NJ, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Mike Stelmah as Vice President, [...]
Dr. Sheldon Marks Authors Definitive Medical Textbook on Vasectomy Reversal
06/11/2018
Springer Publishing Releases First Comprehensive Medical Guide Written by Leading Specialist in Male Reproductive Restoration TUCSON, Ariz., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Dr. Sheldon H.F. Marks, founder of the [...]
Crown Bioscience to Showcase Scientific Expertise at the EORTC-NCI-AACR
06/11/2018
New model data released including Prostate Cancer PDX and humanized target models for the evaluation of combination human checkpoint inhibitors SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global [...]
Marrone Bio Innovations Announces International Distribution Partnership with Agricultural Materials Company (AMC-TR) in Turkey
06/11/2018
DAVIS, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that it has signed [...]
Insmed to Present at Three November Conferences
06/11/2018
BRIDGEWATER, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]
Albireo to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 13, 2018
06/11/2018
BOSTON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its third quarter [...]
The Crucial Role of Genetics in the Future of the Cannabis Industry -- CFN Media
06/11/2018
SEATTLE, Nov. 06, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
ATW Tech Announces Signature of a Letter of Intent for Major Acquisition of Greywolf Entertainment Group
06/11/2018
MONTREAL, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ ATW Tech ”) (TSX-V: ATW) announces today the signature of a letter of intent for the acquisition from Fastrack Trust (the “ Trust ”) of all of the outstanding [...]
ATW Tech annonce la signature d’une lettre d’intention pour l’acquisition majeure du Groupe Greywolf Entertainment
06/11/2018
MONTRÉAL, 06 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech ») ( TSX-V : ATW ), annonce aujourd'hui la signature d’une lettre d’intention visant l’acquisition de la totalité des actions de 6855318 Canada Ltd et [...]
Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s Disease
06/11/2018
ROCHESTER, N.Y., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]

Pages